The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Salvage high-dose chemotherapy (HDCT) for relapsed primary mediastinal nonseminomatous germ-cell tumors (PMNSGCT).
 
Fadi Taza
No Relationships to Disclose
 
Rafat Abonour
Consulting or Advisory Role - BMS (Inst); Genentech; Janssen Oncology; Takeda
Research Funding - Janssen (Inst)
 
Sandra K. Althouse
No Relationships to Disclose
 
Ryan Ashkar
No Relationships to Disclose
 
Mohammad Issam Abu Zaid
Stock and Other Ownership Interests - Pieris Pharmaceuticals
Consulting or Advisory Role - Syndax
Research Funding - Incyte (Inst); Janssen (Inst); Pharmacyclics (Inst); Syndax (Inst)
 
Nasser H. Hanna
Honoraria - UpToDate
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Merck KGaA (Inst)
 
Kenneth A. Kessler
No Relationships to Disclose
 
Nabil Adra
Consulting or Advisory Role - Astellas Pharma; Aveo; Bristol Myers Squibb Foundation; Bristol Myers Squibb Foundation; Exelixis; Merck; Sanofi
Research Funding - Exelixis (Inst); Genentech (Inst); Merck (Inst)
 
Lawrence H. Einhorn
Stock and Other Ownership Interests - Amgen